Viking Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Viking Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Viking Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Viking Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $7.4M | 90k | 82.00 |
| 2023-12-31 | $1.6M | 88k | 18.61 |
| 2023-09-30 | $1.1M | 96k | 11.07 |
| 2023-06-30 | $1.8M | 113k | 16.21 |
| 2023-03-31 | $892k | 54k | 16.65 |
| 2022-06-30 | $0 | 36 | 0.00 |
| 2022-03-31 | $147k | 49k | 3.00 |
| 2021-12-31 | $227k | 50k | 4.50 |
| 2021-09-30 | $284k | 44k | 6.41 |
| 2021-06-30 | $239k | 40k | 6.03 |
| 2021-03-31 | $740k | 65k | 11.36 |
| 2020-12-31 | $845k | 151k | 5.60 |
| 2020-09-30 | $1.3M | 217k | 5.82 |
| 2020-06-30 | $1.4M | 188k | 7.21 |
| 2020-03-31 | $426k | 125k | 3.40 |
| 2019-12-31 | $1.1M | 140k | 8.03 |
| 2019-09-30 | $271k | 39k | 6.88 |
| 2019-06-30 | $286k | 35k | 8.31 |
| 2019-03-31 | $392k | 38k | 10.31 |
| 2018-12-31 | $233k | 30k | 7.67 |
| 2018-06-30 | $818k | 87k | 9.46 |